High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Bob Löwenberg(Unknown), Gregor Verhoef(Universitair Ziekenhuis Leuven)

New England Journal of Medicine

September 23, 2009

10.1056/nejmoa0901409

Cited by 821

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

|Blood|2016|5.9k

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

|Blood|2009|3.4k

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

|Blood|2022|3k

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

|Cancer Cell|2010|2.7k

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

|Journal of Clinical Oncology|2003|2.7k